A study to evaluate the effect of Ayurvedic Treatment with Jeevaniya Gana Churna and Triphala Churna for General Weakness due to Vitamin B12 Deficiency.

Efficacy of Jeevaniya Gana Churna Along with Triphala Churna and Methylcobalamin Tablet in the Management of Daurbalya (~General Debility) due to Vitamin B12 Deficiency: An Open Labelled Randomized Controlled Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/110991

Enrollment

Registered

2026-05-25

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E538- Deficiency of other specified B group vitamins

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants willing to enroll for the study. 2. Participants from 18 to 60 years of age group irrespective of the gender, cast, religion, occupation and financial status. 3. Participants fulfilling diagnostic criteria. 4. Participants using milk and milk products in their routine diet. 5. Participants with Serum Vitamin B12 levels less than 200pg/ml. 6. Participants who are not taking any Vitamin B12 supplements for past 3 months.

Exclusion criteria

Exclusion criteria: 1. Participants with known cases of hormonal, hepatic, renal disorder and autoimmune diseases. 2. Participants with acute or chronic metabolic disorders. 3. Pregnant and Lactating women. 4. Chronic alcoholics. 5. Participants on drugs like anti-diabetic, anti-tubercular, antibiotics, anti-seizures, antacids such as proton pump inhibitor (PPI) and histamine 2 receptor antagonists (H2RA), colchicine, ethanol.

Design outcomes

Primary

Measure	Time frame
1. Improvement in the Serum Vitamin B12 level. 2. Improvement in the gradation of Daurbalya assessment scale. 3. Improvement in gradation of symptoms of Panduroga assessment scale.Timepoint: Group A - 60 Days Group B - 60 Days	—

Secondary

Measure	Time frame
1. Improvement in CBC profile. 2. Improvement in QOL. 3. Improvement in Mini-Cog assessment.Timepoint: 60 Days	—

Countries

India

Contacts

Public ContactDr Shalinee Kumari Mishra

Institute of Teaching and Research in Ayurveda, Jamnagar

drshalinee@itra.edu.in9664540469

Outcome results